Effect of acetazolamide and subsequent ventriculo-peritoneal shunting on clinical signs and ventricular volumes in dogs with internal hydrocephalus

Acta Veterinaria Scandinavica

Malgorzata Kolecka¹  Nele Ondreka¹  Andreas Moritz¹  Martin Kramer¹  Martin J. Schmidt¹ 

[1] Department of Veterinary Clinical Sciences, Small Animal Clinic, Justus-Liebig-University, Frankfurter Straße 108, Giessen, 35392, Germany

关键词: Cerebrospinal fluid;    Ventriculo-peritoneal shunting;    Carbonic anhydrase inhibitor;    Hydrocephalus;   

Others  :  1224040
DOI  :  10.1186/s13028-015-0137-8

 received in 2015-03-12, accepted in 2015-08-08,  发布年份 2015

【 摘 要 】

Background

Acetazolamide is recommended for the reduction of cerebrospinal fluid production in canine internal hydrocephalus. The efficacy of the drug in terms of alleviation of the clinical symptoms and the restoration of normal ventricular volume has not been documented. We hypothesize that acetazolamide inadequately improve clinical signs and has no effect on the ventricular volume. Six dogs with internal hydrocephalus underwent neurological examination and were examined by magnetic resonance imaging, on the day of the diagnosis, after treatment with acetazolamide directly before surgery, and 6 weeks after implantation of a vetriculo-peritoneal shunt due to lack of improvement after medical therapy with 10 mg/kg acetazolamide three times daily (TID). The ventricular volume in relation to the total brain volume was determined on each occasion. The changes in relative ventricular volume and of the neurological status were assessed and compared.

Results

McNemar’s test revealed no significant differences in clinical symptoms before and after medical treatment (P > 0.05). However, clinical symptoms changed significantly after surgical treatment (P = 0.001). The ventricle-brain ratio was not significantly changed after therapy with acetazolamide (P > 0.05); however, after subsequent shunt implantation, it was significantly reduced (P = 0.001).

Conclusion

Acetazolamide (10 mg/kg TID) showed no effects on clinical signs or ventricular volume in dogs with internal hydrocephalus. After subsequent ventriculo-peritoneal shunting, the dogs had a significantly reduced cerebral ventricular volume and five out of six dogs had no abnormal findings in neurological examination.

【 授权许可】

   
2015 Kolecka et al.

【 图 表 】

Fig.1.

【 参考文献 】

• [1]DeLahunta A, Glass E (2014) Malformations. In: Veterinary neuroanatomy and clinical neurology. Saunders Elsevier, Missouri, pp 37–53
• [2]Lorenz MD, Coates JR, Kent M (2011) Stupor and coma. In: Handbook of veterinary neurology. Elsevier Saunders, Missouri, pp 346–383
• [3]Platt S, Garosi L (2013) Hydrocephalus. In: Small animal neurological emergencies. Manson Publishing/The Veterinary Press, pp 147–150
• [4]Gandini G, Jaggy A, Challande-Kathmann I (2010) Diseases of the cerebrum. In: Jaggy A, Platt SR (eds) Small animal neurology. Schlütersche Verlagsgesellschaft GmbH & Co. KG, Hannover, pp 427–466
• [5]Biel M, Kramer M, Forterre F, Jurina K, Lautersack O, Failing K, Schmidt MJ. Outcome of ventriculoperitoneal shunt implantation for treatment of congenital internal hydrocephalus in dogs and cats: 36 cases (2001–2009). J Am Vet Med Assoc. 2013; 242:948-958.
• [6]Laubner S, Ondreka N, Failing K, Kramer M, Schmidt M. Magnetic resonance imaging signs of high intraventricular pressure—comparison of findings in dogs with clinically relevant internal hydrocephalus and asymptomatic dogs with ventriculomegaly. BMC Vet Res. 2015; 11:181. BioMed Central Full Text
• [7]Vullo T, Deo-Narine V, Stallmeyer MJ, Gomez DG, Cahill PT. Quantitation of normal canine hippocampus formation volume: correlation of MRI with gross histology. Magn Reson Imaging. 1996; 14:657-662.
• [8]Montie EW, Pussini N, Schneider GE, Battey TW, Dennison S, Barakos J, Gulland F. Neuroanatomy and volumes of brain structures of a live California sea lion (Zalophus californianus) from magnetic resonance images. Anat Rec. 2009; 292:1523-1547.
• [9]Kennedy CR, Ayers S, Campbell MJ, Elbourne D, Hope P, Johnson A. Randomized controlled trial of acetazolamide and furosemide in posthemorrhagic ventricular dilation in infancy: follow-up at 1 year. Pediatrics. 2001; 108:597-607.
• [10]Itoh T, Nishimura R, Matsunaga S, Kadosawa T, Mochizuki M, Sasaki N. Syringomyelia and hydrocephalus in a dog. J Am Vet Med Assoc. 1996; 209:934-936.
• [11]Schwartz TH, Yoon SS, Cutruzzola FW, Goodman RR. Third ventriculostomy: post-operative ventricular size and outcome. Minim Invas Neurosurg. 1996; 39:122-129.
• [12]Yamada H, Yokota A, Furuta A, Horie A. Reconstitution of shunted mantle in experimental hydrocephalus. J Neurosurg. 1992; 76:856-862.
• [13]Vogh BP. The relation of choroid plexus carbonic anhydrase activity to cerebrospinal fluid formation: study of three inhibitors in cat with extrapolation to man. J Pharmacol Exp Ther. 1980; 213:321-331.
• [14]Friedland BR, Maren TH. Pharmacology of the eye—carbonic anhydrase: pharmacology of inhibitors and treatment of glaucoma. Handb Exp Pharmacol. 1994; 69:279-309.
• [15]Oppelt WW, Patlak CS, Rall DP. Effect of certain drugs on cerebrospinal fluid production in the dog. Am J Physiol. 1964; 206:247-250.
• [16]Holloway LS, Cassin S. Effects of acetazolamide and ouabain on CSF production rate in newborn dogs. Am J Physiol. 1972; 223:503-506.
• [17]Nógrádi A, Kelly C, Carter ND. Localization of acetazolamide-resistant carbonic anhydrase III in human and rat choroid plexus by immunocytochemistry and in situ hybridisation. Neurosci Lett. 1993; 151:162-165.